[Effectiveness of an intervention programme to improve oral anti-coagulation treatment for patients with chronic auricular fibrillation in a health district].
作者信息
Sobrequés J, Espinasa J, Cebrià J
出版信息
Aten Primaria. 2002 Nov 30;30(9):588-9. doi: 10.1016/s0212-6567(02)79111-7.
Abstract
摘要
相似文献
1
[Effectiveness of an intervention programme to improve oral anti-coagulation treatment for patients with chronic auricular fibrillation in a health district].[一项改善某健康区慢性心房颤动患者口服抗凝治疗的干预项目的效果]
Aten Primaria. 2002 Nov 30;30(9):588-9. doi: 10.1016/s0212-6567(02)79111-7.
2
[Evaluation of a programme to use capillary blood to monitor orally taken anticoagulants in basic health areas far from the hospital].[一项关于在远离医院的基层卫生区域使用毛细血管血监测口服抗凝剂的项目评估]
Aten Primaria. 2002 Feb 28;29(3):194-5. doi: 10.1016/s0212-6567(02)70534-9.
3
Causes and Predictors of Death in Atrial Fibrillation Patients Initiating Treatment With Direct Oral Anticoagulants.
Rev Esp Cardiol (Engl Ed). 2018 Jun;71(6):500-503. doi: 10.1016/j.rec.2017.03.032. Epub 2017 Jun 7.
4
[Validation of satisfaction questionnaire ACTS in outpatients with atrial fibrillation treated with oral anticoagulants in Spain. ALADIN Study].[西班牙口服抗凝剂治疗心房颤动门诊患者满意度问卷ACTS的验证。ALADIN研究]
Med Clin (Barc). 2016 Sep 2;147(5):192-198. doi: 10.1016/j.medcli.2016.05.024. Epub 2016 Jul 14.
5
[Use of non-vitamin K antagonist oral anticoagulants in Primary Care: ACTUA study].[基层医疗中使用非维生素K拮抗剂口服抗凝剂：ACTUA研究]
Semergen. 2017 Oct;43(7):477-485. doi: 10.1016/j.semerg.2016.09.003. Epub 2016 Oct 29.
6
[What would you do with a patient with non-valvular atrial fibrillation treated with direct-acting oral anticoagulants who had to undergo gastroscopy or colonoscopy?].对于正在接受直接口服抗凝剂治疗的非瓣膜性心房颤动患者，若其必须接受胃镜检查或结肠镜检查，你会怎么做？
Semergen. 2019 Apr;45(3):197-202. doi: 10.1016/j.semerg.2019.01.003. Epub 2019 Mar 12.
7
Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants.启动直接口服抗凝剂的心房颤动患者瓣膜病的患病率及其预后意义
Rev Esp Cardiol (Engl Ed). 2019 Nov;72(11):935-943. doi: 10.1016/j.rec.2018.08.026. Epub 2018 Nov 27.
8
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.直接口服抗凝剂在心房颤动合并心脏瓣膜病变患者中的应用。
J Am Heart Assoc. 2016 Feb 18;5(2):e002776. doi: 10.1161/JAHA.115.002776.
9
[Low percentage of oral anticoagulation in nonagenarians with atrial fibrillation].[非agenarians房颤患者口服抗凝治疗比例低] （注：这里“nonagenarians”一般指九十多岁的人，可能原文表述有一定问题，推测是想说九十岁及以上老人之类的意思）
Rev Clin Esp. 2006 Sep;206(8):410-1. doi: 10.1157/13090516.
10
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study.真实世界中非瓣膜性心房颤动患者使用直接口服抗凝剂与维生素K拮抗剂的比较。FANTASIIA研究。
Rev Esp Cardiol (Engl Ed). 2020 Jan;73(1):14-20. doi: 10.1016/j.rec.2019.02.021. Epub 2019 May 31.
引用本文的文献
1
[Characteristics of oral anti-coagulation treatment in high-risk chronic auricular fibrillation].[高危慢性心房颤动患者口服抗凝治疗的特点]
Aten Primaria. 2004 Nov 15;34(8):414-9. doi: 10.1016/s0212-6567(04)78925-8.
2
[Impact of a program to improve appropriate prescribing of medications in residential facilities for older persons. Results after one year].[一项改善老年人居住设施中药物合理处方项目的影响。一年后的结果]
Aten Primaria. 2004 Mar 15;33(4):174-80. doi: 10.1016/s0212-6567(04)79389-0.
本文引用的文献
1
[Oral anticoagulation treatment in patients with non-valvular auricular fibrillation].非瓣膜性心房颤动患者的口服抗凝治疗
Aten Primaria. 2002 Sep 30;30(5):284-9. doi: 10.1016/s0212-6567(02)79029-x.
2
[Uncertainty and the taking of clinical decisions].[不确定性与临床决策的制定]
Aten Primaria. 2001 Nov 15;28(8):560-4. doi: 10.1016/s0212-6567(01)70448-9.
3
[Characteristics of primary care clinical guidelines associated with greater structural quality of the document].[与文档更高结构质量相关的初级保健临床指南的特征]
Aten Primaria. 2001 Nov 15;28(8):525-34. doi: 10.1016/s0212-6567(01)70442-8.
4
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.美国心脏病学会/美国心脏协会/欧洲心脏病学会心房颤动患者管理指南：执行摘要。美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南与政策会议委员会（心房颤动患者管理指南制定委员会）报告：与北美心脏起搏和电生理学会合作制定。
J Am Coll Cardiol. 2001 Oct;38(4):1231-66. doi: 10.1016/s0735-1097(01)01587-x.
5
Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enough.针对患有心房颤动且有中风风险因素的患者进行抗凝治疗。华法林可将风险降低三分之二，但医生的处方量仍不足。
BMJ. 2000 May 6;320(7244):1219-20. doi: 10.1136/bmj.320.7244.1219.
Zotero 插件